Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Solasia Pharma KK ( (JP:4597) ) has issued an update.
Solasia Pharma reported significant financial results for the fiscal year ending December 31, 2024, showing a decrease in revenue and an increase in operating losses compared to the previous year. The decline in revenue and increased losses suggest operational challenges, impacting the company’s financial health and positioning in the pharmaceutical industry.
More about Solasia Pharma KK
Solasia Pharma K.K. is a pharmaceutical company listed on the Tokyo Stock Exchange. The company is focused on developing and commercializing oncology treatment products and has a strategic focus on the Asian market.
YTD Price Performance: 21.05%
Average Trading Volume: 304
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €53.48M
See more insights into 4597 stock on TipRanks’ Stock Analysis page.